<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001665141</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001099800</issuerCik>
      <issuerName>Edwards Lifesciences Corp</issuerName>
      <secFileNumber>001-15525</secFileNumber>
      <issuerAddress>
        <com:street1>ONE EDWARDS WAY</com:street1>
        <com:city>IRVINE</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92614</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>9492502500</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Zovighian Bernard J</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab &amp; Co., Inc.</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>36874</noOfUnitsSold>
      <aggregateMarketValue>2873775.00</aggregateMarketValue>
      <noOfUnitsOutstanding>575800000</noOfUnitsOutstanding>
      <approxSaleDate>05/12/2026</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/03/2026</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Lapse</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>EDWARDS LIFESCIENCES CORPORATION</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>523</amountOfSecuritiesAcquired>
      <paymentDate>05/03/2026</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/07/2026</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Lapse</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>EDWARDS LIFESCIENCES CORPORATION</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>4222</amountOfSecuritiesAcquired>
      <paymentDate>05/07/2026</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/08/2026</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Lapse</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>EDWARDS LIFESCIENCES CORPORATION</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>5489</amountOfSecuritiesAcquired>
      <paymentDate>05/08/2026</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/11/2026</acquiredDate>
      <natureOfAcquisitionTransaction>PSU / RSU</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>EDWARDS LIFESCIENCES CORPORATION</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>26640</amountOfSecuritiesAcquired>
      <paymentDate>05/11/2026</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Bernard J Zovighian</name>
        <address>
          <com:street1>ONE EDWARDS WAY</com:street1>
          <com:city>IRVINE</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92614</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Edwards Lifesciences Corp</securitiesClassTitle>
      <saleDate>02/12/2026</saleDate>
      <amountOfSecuritiesSold>22430</amountOfSecuritiesSold>
      <grossProceeds>1719742.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>Shares sold in the BERNARD AND CECILE ZOVIGIAN FAMILY TRUST and may be sold over various dates.</remarks>
    <noticeSignature>
      <noticeDate>05/12/2026</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>12/12/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>Bernard J Zovighian TTEE</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
